Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
PDS Biotechnology Corporation (PDSB) had Stock-Based Compensation of $1.70M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.43M |
|
-- |
|
-- |
|
$7.62M |
|
$-7.62M |
|
$-1.81M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-7.62M |
|
$-6.49M |
|
45.90M |
|
45.90M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$33.65M |
|
$0.13M |
|
$6.83M |
|
$40.48M |
|
$11.53M |
|
$12.98M |
|
$12.98M |
|
$24.52M |
|
$15.96M |
|
$15.96M |
|
$15.96M |
|
46.63M |
|
| Cash Flow Statement Financials | |
$-18.13M |
|
-- |
|
$8.32M |
|
$41.69M |
|
$31.87M |
|
$-9.82M |
|
|
Stock-Based Compensation |
$1.70M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
0.45 |
|
1.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.11% |
|
-59.11% |
|
-23.31% |
|
-32.59% |
|
$0.34 |
|
$-0.40 |
|
$-0.40 |
|